“SK-developed corona vaccine, phase 3 clinical trial after securing interim results in the third quarter”
Cellmaterapeutics completes application for approval for Phase 3 clinical trial in France for COVID-19 treatment
Ministry of Food and Drug Safety’s Central Pharmaceutical Affairs Commission “Recommendation for use of celltrion antibody therapy for moderate and high-risk patients with mild symptoms”: Dong-A Science